PEPTONIC Medical AB

Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.

Quotes for PEPTONIC Medical AB

Right Now

+/-
-0.0004
%
−3,17%
Latest
0.0122
High
0.013
Low
0.0114
Volume
4 777 965
Turnover (SEK)
56 967
Market Value (MSEK)
18,7
Time (Latest trade)

Board

CEO

  • Anna Linton

Chairperson of the Board

  • Anders Blom

Board

  • Anders Norling
  • Daniel Rudeklint
  • Kristina Ingvar
  • Tarek Schoeb
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Analysguiden – Intervju med Peptonic

    Peptonic Medical - Småbolagsdagen Stockholm 3 juni 2019

    VD Johan Inborr intervjuas hos Aktiespararna

    Analysguiden - Intervju med Johan Inborr

    Largest Owners

    Name Capital % Votes % Date
    Maida Vale Capital AB 15,69 15,69 2024-03-26
    Vidarstiftelsen 11,07 11,07 2024-03-26
    Avanza Pension 5,07 5,07 2024-03-26
    Heli Kurjanen 3,71 3,71 2022-12-31
    Tarek Nabil Shoeb 2,87 2,87 2024-03-26
    Stein Jens-Peter 2,87 2,87 2024-03-26
    Mika Kurjanen 1,93 1,93 2022-12-28
    Nordnet Pensionsförsäkring 1,85 1,85 2024-03-26
    Quartier Latin AB 1,37 1,37 2024-03-26
    Henrik Hahn 1,26 1,26 2024-03-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2024-05-07 Delårsrapport 2024-Q1

    • 2024-05-21 Årsstämma 2023

    • 2024-08-13 Delårsrapport 2024-Q2

    • 2024-11-06 Delårsrapport 2024-Q3

    • 2025-02-21 Bokslutskommuniké 2024

    Annual reports, prospectus etc.